Accretion Pharmaceuticals Ipo
Objects of the Issue
Capital expenditure towards purchase of new equipment/ machineries, etc.
Capital expenditure towards upgradation of existing manufacturing facility
Repayment/prepayme nt of certain borrowings availed by the Company
Funding working capital requirements
General Corporate Purpose
Accretion Pharmaceuticals IPO Review
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Jawa Capital Services Private Limited
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 1200 | ₹1,21,200 |
Retail Maximum | 1 | 1200 | ₹1,21,200 |
S-HNI Minimum | 2 | 2,400 | ₹2,42,400 |
IPO Open Date: | May 14, 2025 |
IPO Close Date: | May 16, 2025 |
Basis of Allotment: | May 19, 2025 |
Refunds: | May 20, 2025 |
Credit to Demat Account: | May 20, 2025 |
IPO Listing Date: | May 21, 2025 |
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹22.58 | ₹783.90 | ₹0.08 | ₹17.74 |
2023 | ₹29.53 | ₹1472.25 | ₹0.10 | ₹20.58 |
2024 | ₹33.94 | ₹2883.26 | ₹3.88 | ₹27.05 |
July 2024 | ₹11.89 | ₹1423.72 | ₹1.57 | ₹29.34 |
KPI | Values |
ROE: | 72.80% |
ROCE: | 36.73% |
EBITDA Margin: | 23.06% |
PAT Margin: | 11.51% |
Debt to equity ratio: | 2.52 |
Earning Per Share (EPS): | ₹9.69 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 72.47% |
Net Asset Value (NAV): | ₹- |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
Sakar Healthcare Limited | 5.64 | 65.30 | 4.45% | 120.65 | – Cr. |
Lincoln PharmaceuticalsLimited | 46.58 | 12.58 | 15.74% | 295.98 | – Cr. |
Sotac PharmaceuticalsLimited | 5.24 | 23.09 | 11.91% | 43.69 | – Cr. |
IPO Open Date: | May 14, 2025 |
IPO Close Date: | May 16, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹96 to ₹101 Per Share |
Issue Size: | Approx ₹29.75 Crores |
Fresh Issue: | Approx ₹29.75 Crores |
Issue Type: | Book Built Issue |
IPO Listing: | NSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |